SCHEMBL6602469

SCHEMBL6602469

CN(c1nc(C(N)=O)cs1)S(C)(=O)=O

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTR2B P41595 1/20 0.39
ACHE P22303 1/20 0.38
CYP2C19 P33261 1/20 0.35
ENPP2 Q13822 1/20 0.34
LMNA P02545 1/20 0.31
RAB9A P51151 2/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
ALDH1A1 P00352 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
NPC1 O15118 1/20 0.30
ADORA3 P0DMS8 1/20 0.30
TSHR P16473 1/20 0.30
MC4R P32245 1/20 0.30
ADRA1A P35348 1/20 0.30
MC3R P41968 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30889068 0.85 L3MBTL1 (0.42) ACHEALDH1A1L3MBTL1
Hydrochloric Acid SCHEMBL5013616 0.80 MEN1 (0.43) HTR2BACHECYP2C19LMNARAB9A
SCHEMBL30889054 0.73 NPC1 (0.38) ACHECYP2C19RAB9AL3MBTL1NPC1
SCHEMBL3121433 0.73 HTR2B (0.42) HTR2BACHECYP2C19LMNARAB9A
SCHEMBL17993901 0.72 MEN1 (0.37) MEN1KMT2A
SCHEMBL28191547 0.72 HTR2B (0.37) HTR2BACHECYP2C19RAB9AMEN1
SCHEMBL29050259 0.70 MMP1 (0.44) HTR2BACHECYP2C19ENPP2LMNA
SCHEMBL6570711 0.69 HDAC3 (0.44) HTR2BACHEL3MBTL1
SCHEMBL30889045 0.68 ADORA3 (0.43) CYP2C19RAB9AMEN1KMT2AALDH1A1
SCHEMBL6607797 0.68 ALDH1A1 (0.41) LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1395251-A2 AMINEDIOLS AS AGENTS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2004-03-10 EP disclosed
WO-2002100818-A2 AMINEDIOLS AS AGENTS FOR THE TREATMENT OF ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-12-19 WO disclosed